HIV-1 Tat Upregulates the Receptor for Advanced Glycation End Products and Superoxide Dismutase-2 in the Heart of Transgenic Mice.
HIV-1 Tat Upregulates the Receptor for Advanced Glycation End Products and Superoxide Dismutase-2 in the Heart of Transgenic Mice.
复制标题
DOI:
10.3390/v14102191
复制
发表时间:
2022-10-04
期刊:
影响因子:
--
通讯作者:
Paris JJ
中科院分区:
文献类型:
--
作者:
Qrareya AN;Wise NS;Hodges ER;Mahdi F;Stewart JA Jr;Paris JJ
Cardiovascular disorder (CVD) is a common comorbidity in people living with HIV (PLWH). Although the underlying mechanisms are unknown, virotoxic HIV proteins, such as the trans-activator of transcription (Tat), likely contribute to CVD pathogenesis. Tat expression in mouse myocardium has been found to induce cardiac dysfunction and increase markers of endothelial toxicity. However, the role that Tat may play in the development of CVD pathogenesis is unclear. The capacity for Tat to impact cardiac function was assessed using AC16 human cardiomyocyte cells and adult male and female transgenic mice that conditionally expressed Tat [Tat(+)], or did not [Tat(−)]. In AC16 cardiomyocytes, Tat increased intracellular calcium. In Tat(+) mice, Tat expression was detected in both atrial and ventricular heart tissue. Tat(+) mice demonstrated an increased expression of the receptor for advanced glycation end products and superoxide dismutase-2 (SOD-2) in ventricular tissues compared to Tat(−) controls. No changes in SOD-1 or α-smooth muscle actin were observed. Despite Tat-mediated changes at the cellular level, no changes in echocardiographic measures were detected. Tat(+) mice had a greater proportion of ventricular mast cells and collagen; however, doxycycline exposure offset the latter effect. These data suggest that Tat exposure promotes cellular changes that can precede progression to CVD.
登录
查看更多内容
影响因子:
14.9
作者:
Baldarelli RM;Smith CM;Finger JH;Hayamizu TF;McCright IJ;Xu J;Shaw DR;Beal JS;Blodgett O;Campbell J;Corbani LE;Frost PJ;Giannatto SC;Miers DB;Kadin JA;Richardson JE;Ringwald M
通讯作者:
Ringwald M
影响因子:
4.2
作者:
El Kamari V;Rodriguez K;Moser C;Currier JS;Kelesidis T;Stein JH;Brown TT;Howell SK;Beisswenger PJ;McComsey GA
通讯作者:
McComsey GA
影响因子:
3.1
作者:
Fukami, Kei;Yamagishi, Sho-ichi;Okuda, Seiya
通讯作者:
Okuda, Seiya
影响因子:
37.8
作者:
Feinstein MJ;Hsue PY;Benjamin LA;Bloomfield GS;Currier JS;Freiberg MS;Grinspoon SK;Levin J;Longenecker CT;Post WS
通讯作者:
Post WS
影响因子:
4.3
作者:
Chen Q;Wu Y;Yu Y;Wei J;Huang W
通讯作者:
Huang W